The Pyo 2007 study (PMID 17703734) reported that AHK-Cu raised VEGF production in the treated cells
Choosing a clean, transparently sourced formulation is essential when your goal is to support an organ that is already working hard
has served on advisory boards for Wilson Therapeutics, Vivet Therapeutics, GMP-Orphan SAS and Kadmon Holdings, is a speaker for Gilead Sciences and is on the Medical Advisory Committee of the Wilson Disease Association
PMID: 26836888
Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway
Ethoxydiglycol, 3-O-Ethyl Ascorbic Acid, Tetrahexyldecyl Ascorbate, Dimethyl Isosorbide, Isodecyl Neopentanoate, Glutathione (L), Superoxide Dismutase, Ethylhexylglycerin, Caprylyl Glycol, Phenoxyethanol